Sertal

Sertraline

Composition : Sertraline Hydrochloride BP 25 mg, 50 mg & 100 mg Tablet.

Indications : Sertal is indicated for the treatment of symptoms of depressive illness, including accompanying symptoms of anxiety. Following satisfactory response continuation with Sertal therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes, including accompanying symptoms of anxiety.

Dosage and administration :Dosage for Adult : Major Depressive Disorder and Obsessive- Compulsive Disorder-Sertal treatment should be administered at a dose of 50mg once daily. Panic Disorder, Posttraumatic Stress Disorder and Social Anxiety Disorder- Sertal treatment should be initiated with a dose of 25mg once daily. After one week, the dose should be increased to 50mg once daily. Prementstrual Dysphoric Disorder- Sertal treatment should be initiated with a dose of 50mg/day, either daily throughout the menstrual cycle or limited to the luteal phase of the menstrual cycle, depending on physician assessment.

Dosage for Pediatric Population : Sertal treatment should be initiated with a dose of 25mg once daily in children (ages 6-12) and at a dose of 50mg once daily in adolescents (ages 13-17). Sertal should be administered once daily, either in the morning or evening. Or as directed by the registered physician.

Use in pregnancy and lactation : There are no adequate and well controlled studies in pregnant women, since animal reproduction studies are not always predictive of human response. Sertal should be used during pregnancy only if the perceived benefits outweigh the risks. Limited data concerning sertraline levels in breast milk are available, hence it is not recommended in nursing mother. Pregnancy Category C by FDA.

Packing :

Sertal-25 : 5 x 10's tablets in blister pack.

Sertal-50 : 5 x 10's tablets in blister pack.

Sertal-100 : 3 x 10's tablets in blister pack.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2022 Designed and Developed by ATI Limited.